The European Quantitative Structure-Activity Relationships (EuroQSAR) Symposia are major scientific events that have been organized in different cities of Europe since 1973. They have the fascinating scope to promote and disseminate advances in rational approaches in drug design and discovery and ensure a worldwide attendance of prominent scientists from both academia and industry.
The 22nd EuroQSAR 2018 symposium, entitled “Translational and Health Informatics: Implications for Drug Discovery”, will take place September 16-20, 2018 in Thessaloniki, Greece. It is a Turkish-Greek co-organization and an EFMC sponsored event.
To honor his impact of his contributions in the field of computer-aided drug discovery (CADD) and QSAR, the 22 nd EuroQSAR Symposium is dedicated to the memory of Prof. Toshio Fujita (1929-2017).
The symposium will focus on:
The scientific program of the Symposium will include plenary lectures, keynote lectures, oral communications, companies' workshops, poster presentations and a commercial exhibition.
The symposium will take place in Thessaloniki, a cozy and cosmopolitan European city, which integrates the ancient Greek, Byzantine, Ottoman and Jewish culture, art, history and cuisine. In the crossroad of Balkans and Middle East, it is situated at the Aegean sea, close to beautiful beaches and Mount Olympus, while it has easy access from most European cities. It is the area where Aristotle elaborated his philosophy and Alexander the Great started the era which changed ancient world and history.
The venue will be one of the well-known 5 stars hotels, Grand Hotel Palace, which is constructed and furnished resembling a royal palace.
We look forward to your active participation!
Prof. Ismail Yalcin
Prof. Anna Tsantili and Prof. Esin Aki-Yalcin